Immunophilin ligands can prevent progressive dopaminergic degeneration in animal models of Parkinson's disease. (Q43563917)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11285005%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Immunophilin ligands can prevent progressive dopaminergic degeneration in animal models of Parkinson's disease (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11285005%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11285005%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

author name string

L C Costantini

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11285005%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

D Cole

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11285005%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

P Chaturvedi

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11285005%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

language of work or name

English

0 references

publication date

1 March 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11285005%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Neuroscience

6 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11285005%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11285005%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11285005%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

1085-1092

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11285005%20AND%20SRC:MED&resulttype=core&format=json

Differential effects of glial cell line-derived neurotrophic factor and neurturin on developing and adult substantia nigra dopaminergic neurons

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Coenzyme Q10 administration and its potential for treatment of neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Studies on neuroprotective and regenerative effects of GDNF in a partial lesion model of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Glial cell line-derived neurotrophic factor supports survival of injured midbrain dopaminergic neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

A novel immunophilin ligand: distinct branching effects on dopaminergic neurons in culture and neurotrophic actions after oral administration in an animal model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Immunophilin ligands and GDNF enhance neurite branching or elongation from developing dopamine neurons in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Immunosuppressant FK506 enhances phosphorylation of nitric oxide synthase and protects against glutamate neurotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Histological evidence of fetal pig neural cell survival after transplantation into a patient with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Prospects for new restorative and neuroprotective treatments in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Dopamine-rich grafts ameliorate whole body motor asymmetry and sensory neglect but not independent limb use in rats with 6-hydroxydopamine lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Oxidative stress and antioxidant therapy in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Implanted fibroblasts genetically engineered to produce brain-derived neurotrophic factor prevent 1-methyl-4-phenylpyridinium toxicity to dopaminergic neurons in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Cell-mediated delivery of brain-derived neurotrophic factor enhances dopamine levels in an MPP+ rat model of substantia nigra degeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

A nonimmunosuppressant FKBP-12 ligand increases nerve regeneration.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Neurotrophins prevent death and differentially affect tyrosine hydroxylase of adult rat nigrostriatal neurons in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Analysis of the neurotrophic effects of GPI-1046 on neuron survival and regeneration in culture and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Fetal nigral grafts survive and mediate clinical benefit in a patient with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Clinicopathological findings following intraventricular glial-derived neurotrophic factor treatment in a patient with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Trophic and protective effects of growth/differentiation factor 5, a member of the transforming growth factor-beta superfamily, on midbrain dopaminergic neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Human fetal dopamine neurons grafted into the striatum in two patients with severe Parkinson's disease. A detailed account of methodology and a 6-month follow-up

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Long-term improvement in patients with severe Parkinson's disease after implantation of fetal ventral mesencephalic tissue in a cavity of the caudate nucleus: 5-year follow up in 10 patients. Clinica Puerta de Hierro Neural Transplantation Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Glial cell line-derived neurotrophic factor prevents death, but not reductions in tyrosine hydroxylase, of injured nigrostriatal neurons in adult rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Immunosuppressant FK506 promotes neurite outgrowth in cultures of PC12 cells and sensory ganglia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Etiology and pathogenesis of Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Protection and regeneration of nigral dopaminergic neurons by neurturin or GDNF in a partial lesion model of Parkinson's disease after administration into the striatum or the lateral ventricle

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Intrastriatal glial cell line-derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Stereotactic pallidotomy for the treatment of Parkinson's disease. Efficacy and adverse effects at 6 months in 26 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

High brain densities of the immunophilin FKBP colocalized with calcineurin

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Neurturin protects dopaminergic neurons following medial forebrain bundle axotomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Short- and long-term survival and function of unilateral intrastriatal dopaminergic grafts in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X

Immunophilins mediate the neuroprotective effects of FK506 in focal cerebral ischaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.0953-816X.2001.01473.X